Recommended Dosing of IV Midazolam for Procedural Sedation

Adult Dosing Algorithm

The American Gastroenterological Association recommends an initial intravenous dose of midazolam for procedural sedation in healthy adults younger than 60 years of 1 mg (or no more than 0.03 mg/kg) injected over 1-2 minutes, with additional doses of 1 mg (or 0.02-0.03 mg/kg) administered at 2-minute intervals until adequate sedation is achieved 1, 2
The initial dose for healthy adults under 60 years is 1 mg IV (or no more than 0.03 mg/kg) administered over 1-2 minutes, according to the American Gastroenterological Association 1
A wait time of 2 minutes is recommended to evaluate the sedative effect before administering additional doses, as suggested by the American Gastroenterological Association 1
Additional doses of 1 mg (or 0.02-0.03 mg/kg) should be administered at 2-minute intervals until adequate sedation is achieved, with a maximum total dose of usually not more than 6 mg for routine procedures, as recommended by the American Gastroenterological Association 1

For patients with hepatic or renal impairment, the dose of midazolam should be reduced due to decreased clearance, and titration should be done more carefully with smaller increments, as recommended by clinical guidelines 1, 3

The major side effect of midazolam is respiratory depression, which can be life-threatening when combined with opioids, and has been reported to cause deaths, according to the American Gastroenterological Association 1, 2
A synergistic interaction occurs when midazolam is used with an opioid, requiring dose reduction, as recommended by clinical guidelines 1, 2, 3
Rapid administration of midazolam is associated with an increased risk of apnea, according to the American Gastroenterological Association 1, 2
Monitoring oxygen saturation continuously during and after the procedure is essential, as recommended by clinical guidelines 3

Apnea may occur as long as 30 minutes after the last dose of midazolam, according to the American Gastroenterological Association 1, 2
Flumazenil can be used to reverse life-threatening respiratory depression but will also reverse sedative effects, as recommended by clinical guidelines 3
Patients should be monitored for an extended period after sedation, according to the American Gastroenterological Association 1, 2

The onset of effect of midazolam is 1-2 minutes after IV administration, with a peak effect at 3-4 minutes, and a duration of effect of 15-80 minutes, according to the American Gastroenterological Association 1, 2
Midazolam is 1.5-3.5 times more potent than diazepam, according to the American Gastroenterological Association 1, 2